Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China To Issue Strict Limits On Antibiotic Usage By July; Large Sales Cuts Expected

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's Ministry Of Health is collecting public feedback on a draft version of guidance that will significantly restrict the use of anti-infectives, and is planning to implement a final version in July. The new policy could slow down the rapid growth of China's anti-infective market - the largest drug class in China - which saw a 24.5% compound annual growth rate during 2006-2009

You may also be interested in...



China Further Restricts Antibiotic Use, Expands Monitoring Networks To More Hospitals

As the world’s largest consumer of antibiotics, China will soon implement a new regulation that further restricts use, and expands monitoring of adverse events and drug resistance.

Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?

SHANGHAI - China's State Council Aug. 4 released a formal draft of a new policy to address the abuse of anti-infectives and is soliciting public comments. Surprising analysts, the draft policy is less strict than a previous version that had circulated around industry, leaving the future of China's anti-infective market more difficult to predict

Under Industry Pressure, China Blinks On Restricting Use Of Anti-infectives - Or Does It?

SHANGHAI - China's State Council Aug. 4 released a formal draft of a new policy to address the abuse of anti-infectives and is soliciting public comments. Surprising analysts, the draft policy is less strict than a previous version that had circulated around industry, leaving the future of China's anti-infective market more difficult to predict

Related Content

UsernamePublicRestriction

Register

SC078220

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel